Pediatric-inspired intensified therapy of adult T-ALL reveals the favorable outcome of NOTCH1/FBXW7 mutations, but not of low ERG/BAALC expression: a GRAALL study.
暂无分享,去创建一个
H. Dombret | E. Macintyre | S. Leprêtre | P. Chevallier | M. Béné | X. Thomas | O. Reman | N. Ifrah | N. Vey | P. Rousselot | V. Asnafi | N. Boissel | A. Buzyn | Y. Chalandon | J. Cahn | F. Huguet | R. Ben Abdelali | P. Turlure | T. Leguay | N. Fegueux | E. Tavernier | M. Escoffre‐Barbe | V. Lheritier | M. Escoffre-barbe
[1] Raymond E. Moellering,et al. Direct inhibition of the NOTCH transcription factor complex , 2009, Nature.
[2] C. Bloomfield,et al. Prognostic implications of NOTCH1 and FBXW7 mutations in adult acute T-lymphoblastic leukemia , 2009, Haematologica.
[3] A. Ferrando,et al. Prognostic implications of NOTCH1 and FBXW7 mutations in adults with T-cell acute lymphoblastic leukemia treated on the MRC UKALLXII/ECOG E2993 protocol. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] H. Dombret,et al. NOTCH1/FBXW7 mutation identifies a large subgroup with favorable outcome in adult T-cell acute lymphoblastic leukemia (T-ALL): a Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL) study. , 2009, Blood.
[5] H. Dombret,et al. Pediatric-inspired therapy in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: the GRAALL-2003 study. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] Cheng Cheng,et al. Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia. , 2009, The Lancet. Oncology.
[7] Iannis Aifantis,et al. γ-secretase inhibitors reverse glucocorticoid resistance in T cell acute lymphoblastic leukemia , 2009, Nature Medicine.
[8] E. Raetz,et al. Molecular pathogenesis of T-cell leukaemia and lymphoma , 2008, Nature Reviews Immunology.
[9] J. Soulier,et al. Prognostic and oncogenic relevance of TLX1/HOX11 expression level in T-ALLs. , 2007, Blood.
[10] C. Bloomfield,et al. Low ERG and BAALC expression identifies a new subgroup of adult acute T-lymphoblastic leukemia with a highly favorable outcome. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] Rob Pieters,et al. FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to γ-secretase inhibitors , 2007, The Journal of experimental medicine.
[12] A. Ferrando,et al. The SCFFBW7 ubiquitin ligase complex as a tumor suppressor in T cell leukemia , 2007, The Journal of experimental medicine.
[13] L. Chin,et al. Chromosomally unstable mouse tumours have genomic alterations similar to diverse human cancers , 2007, Nature.
[14] R. Wells. Induction therapy for adults with acute lymphoblastic leukemia , 2006, Current oncology reports.
[15] C. Bloomfield,et al. High expression of the ETS transcription factor ERG predicts adverse outcome in acute T-lymphoblastic leukemia in adults. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] M. Muckenthaler,et al. Activating NOTCH1 mutations predict favorable early treatment response and long-term outcome in childhood precursor T-cell lymphoblastic leukemia. , 2006, Blood.
[17] Jiong Hu,et al. NOTCH1 Mutations in T-Cell Acute Lymphoblastic Leukemia: Prognostic Significance and Implication in Multifactorial Leukemogenesis , 2006, Clinical Cancer Research.
[18] C. Pui,et al. Treatment of acute lymphoblastic leukemia. , 2006, The New England journal of medicine.
[19] F. Alt,et al. Activating Notch1 mutations in mouse models of T-ALL. , 2005, Blood.
[20] M. Caligiuri,et al. Overexpression of the ETS-related gene, ERG, predicts a worse outcome in acute myeloid leukemia with normal karyotype: a Cancer and Leukemia Group B study. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[21] J. Cayuela,et al. Impact of TCR status and genotype on outcome in adult T-cell acute lymphoblastic leukemia: a LALA-94 study. , 2005, Blood.
[22] W. Pear,et al. Regulation of lymphoid development, differentiation, and function by the Notch pathway. , 2005, Annual review of immunology.
[23] H. Dombret,et al. Outcome of treatment in adults with acute lymphoblastic leukemia: analysis of the LALA-94 trial. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[24] Andrew P. Weng,et al. Activating Mutations of NOTCH1 in Human T Cell Acute Lymphoblastic Leukemia , 2004, Science.
[25] Freddy Radtke,et al. Notch regulation of lymphocyte development and function , 2004, Nature Immunology.
[26] M. Caligiuri,et al. BAALC, a novel marker of human hematopoietic progenitor cells. , 2003, Experimental hematology.
[27] M. Caligiuri,et al. BAALC expression predicts clinical outcome of de novo acute myeloid leukemia patients with normal cytogenetics: a Cancer and Leukemia Group B Study. , 2003, Blood.
[28] E. Macintyre,et al. Analysis of TCR, pT alpha, and RAG-1 in T-acute lymphoblastic leukemias improves understanding of early human T-lymphoid lineage commitment. , 2003, Blood.
[29] M. Caligiuri,et al. BAALC, the human member of a novel mammalian neuroectoderm gene lineage, is implicated in hematopoiesis and acute leukemia , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[30] J. Aster,et al. Separation of Notch1 Promoted Lineage Commitment and Expansion/Transformation in Developing T Cells , 2001, The Journal of experimental medicine.
[31] Jon C. Aster,et al. Essential Roles for Ankyrin Repeat and Transactivation Domains in Induction of T-Cell Leukemia by Notch1 , 2000, Molecular and Cellular Biology.
[32] J. Sklar,et al. Exclusive development of T cell neoplasms in mice transplanted with bone marrow expressing activated Notch alleles , 1996, The Journal of experimental medicine.
[33] A Orfao,et al. Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL). , 1995, Leukemia.
[34] J. Sklar,et al. TAN-1, the human homolog of the Drosophila Notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms , 1991, Cell.
[35] R. Gray. A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk , 1988 .
[36] J. Peto,et al. Asymptotically Efficient Rank Invariant Test Procedures , 1972 .
[37] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .
[38] D.,et al. Regression Models and Life-Tables , 2022 .